08 Feb 2025
High-risk TAVI
Facilitators:
M. Miyasaka, N. Wongpraparut
Discussants:
S. Gunasekaran, H. Zhang
Summary
Delve into the management of high-risk TAVI cases in this session. Discover innovative approaches, such as Impella-assisted TAVI in severe bicuspid aortic valve disease with severe left ventricular dysfunction, TAVR for pure native aortic regurgitation in surgically unfit patients, and the use of TAVI as a bridging therapy in patients with cirrhosis awaiting liver transplant. Explore techniques for overcoming challenging scenarios, including calcified peripheral vasculopathy and unexpected valve impediment during TAVI using a balloon-expandable valve in a patient on VA-ECMO support.